| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 02/23/2006 | US20060040384 Serum free cultivation of primate embryonic stem cells |
| 02/23/2006 | US20060040310 Epitope testing using soluble HLA |
| 02/23/2006 | US20060040042 High Gloss Film Coating and Stable Solution Therefor |
| 02/23/2006 | US20060039997 Multiparticulate formulations of lithium salts for oral administration suitable for once-a-day administration |
| 02/23/2006 | US20060039989 Pharmaceutical compositions of cell lysate and processes for the production and use thereof |
| 02/23/2006 | US20060039988 Azithromycin dosage forms with reduced side effects |
| 02/23/2006 | US20060039987 Method and apparatus for producing dry particles |
| 02/23/2006 | US20060039986 Functional material, process for producing functional material and functional member and environment modifying apparatus using the functional material |
| 02/23/2006 | US20060039985 Methotrexate compositions |
| 02/23/2006 | US20060039984 Process for producing fine porous polyimide particle |
| 02/23/2006 | US20060039983 Nanoparticles from supercritical fluid antisolvent process using particle growth and agglomeration retardants |
| 02/23/2006 | US20060039982 Gel materials, medical articles, and methods |
| 02/23/2006 | US20060039981 Taste masked dosage forms and processes for their preparation |
| 02/23/2006 | US20060039980 Polycondensing a polyhydric alcohol monomer having a secondary hydroxyl functional group and an acid monomer having dicarboxylic group; used to control the dose of a drug in a drug release system and is useful as a supporter for regenerating a desired biological tissue of a patient in tissue engineering |
| 02/23/2006 | US20060039979 Drug delivery system using subconjunctival depot |
| 02/23/2006 | US20060039978 Self-forming phospholipidic gels |
| 02/23/2006 | US20060039977 Oral drug delivery system |
| 02/23/2006 | US20060039976 Controlled release composition using transition coating, and method of preparing same |
| 02/23/2006 | US20060039975 Paroxetine formulations |
| 02/23/2006 | US20060039974 Sustained release preparation |
| 02/23/2006 | US20060039973 Effervescent composition including water soluble dietary fiber |
| 02/23/2006 | US20060039972 Effervescent composition including a grape-derived component |
| 02/23/2006 | US20060039971 Effervescent composition including alternative hormone replacement therapy agent |
| 02/23/2006 | US20060039970 Tamper-resistant oral opioid agonist formulations |
| 02/23/2006 | US20060039969 Gastrointestinal side effect reduction with lower mean Maximum concentrations (Cmax) than with an immediate release formulation, but equivalent bioavailability of clarithromycin and a water soluble alginate salt, a complex salt of alginic acid and an organic carboxylic acid |
| 02/23/2006 | US20060039968 Gabapentin tablets and method for their preparation |
| 02/23/2006 | US20060039967 Amino acid-containing chewable |
| 02/23/2006 | US20060039966 Dosage delivery apparatus for improving user acceptance of oral supplements and medicaments and methods for manufacturing same |
| 02/23/2006 | US20060039965 Drug delivery system for hydrophobic drugs |
| 02/23/2006 | US20060039964 Micelle assemblies |
| 02/23/2006 | US20060039963 Lipid-analogo phosphoric acid triesters |
| 02/23/2006 | US20060039962 Amphiphilic compounds and vesicles liposomes for organ-specified drug targeting |
| 02/23/2006 | US20060039961 Percutaneous absorption accelerator |
| 02/23/2006 | US20060039960 Plaster containing fentanyl |
| 02/23/2006 | US20060039959 Film-Shaped Mucoadhesive Administration Forms For Administering Cannabis Agents |
| 02/23/2006 | US20060039958 Multi-layer films having uniform content |
| 02/23/2006 | US20060039957 Multi-layer transmucosal therapeutic system |
| 02/23/2006 | US20060039956 Impregnating solution for cosmetic cloths |
| 02/23/2006 | US20060039953 Water soluble polymer such as pullulan and an antimicrobial effective amount of thymol, methyl salicylate, eucalyptol and/or menthol; killing the plaque-producing germs that cause dental plaque, gingivitis and bad breath |
| 02/23/2006 | US20060039951 Inorganic shaped bodies and methods for their production and use |
| 02/23/2006 | US20060039948 Implant, therapeutic agent and micelle |
| 02/23/2006 | US20060039933 Method for treatment of insect bites |
| 02/23/2006 | US20060039931 Stable cream preparations of phenyl-pyridone compounds for topical application |
| 02/23/2006 | US20060039872 Layered chewing gum tablet |
| 02/23/2006 | US20060039871 Beclomethasone powders has specific particle size distribution; increase bioavailability, prolonged therapeutic effect of the drug substance; aqueous suspension for inhalation; drug delivery method and device; rhinitis treatment |
| 02/23/2006 | US20060039870 Pulmonary delivery of enzymatic medical countermeasures |
| 02/23/2006 | US20060039869 Intranasal delivery of antipsychotic drugs |
| 02/23/2006 | US20060039868 For use in therapy of chronic obstructive pulmonary disease and asthma; an inhalette capsule contains a mixture of coarser and fine excipient particles |
| 02/23/2006 | US20060039864 Abuse-proofed oral dosage form |
| 02/23/2006 | US20060037557 Apparatus and methods for dispensing pet care substances |
| 02/23/2006 | DE102004038886A1 Pharmaceutical formulation useful for treating inflammatory and obstructive respiratory diseases comprises at least one anticholinergic compound, at least one corticosteroid and at least one betamimetic |
| 02/23/2006 | DE102004038862A1 Capsule for investigation and treatment of the digestive tract comprises a housing which completely surrounds a permanent magnet, and incorporates at least one space for at least one medicament |
| 02/23/2006 | DE102004038672A1 Nahrungsergänzungsmittelabgabevorrichtung Nutritional supplements dispenser |
| 02/23/2006 | DE102004038533A1 Wasserhaltige Polymermatrix aus hydrophoben Polymeren Aqueous polymer matrix of hydrophobic polymers |
| 02/23/2006 | CA2799413A1 Therapeutic composition with a botulinum neurotoxin |
| 02/23/2006 | CA2579449A1 Galenic applications of self-emulsifying mixtures of lipidic excipients |
| 02/23/2006 | CA2577386A1 Pulmonary delivery of a nerve agent neutralizing enzyme |
| 02/23/2006 | CA2577345A1 Jelly composition |
| 02/23/2006 | CA2576852A1 Apparatus and method for transdermal delivery of natriuretic peptides |
| 02/23/2006 | CA2576222A1 Compositions and methods for treating lymphoma |
| 02/23/2006 | CA2575532A1 Microprojection apparatus and system with low infection potential |
| 02/23/2006 | CA2575385A1 Aerosol formulation for inhalation, containing an anticholinergenic agent |
| 02/23/2006 | CA2575362A1 Hybrid device for cell therapies |
| 02/23/2006 | CA2575361A1 Implantable devices and methods for delivering drugs and other substances to treat sinusitis and other disorders |
| 02/23/2006 | CA2575155A1 Use of vitamin ds to treat kidney disease |
| 02/23/2006 | CA2575153A1 Use of vitamin d receptor activators or vitamin d analogs to treat cardiovascular disease |
| 02/22/2006 | EP1627911A1 Washing apparatus |
| 02/22/2006 | EP1627645A1 Antitumor agent and process for producing the same |
| 02/22/2006 | EP1627644A1 PREPARTAION FOR EXTERNAL PERCUTANEOUS ADMINISTRATION CONTAINING NON-STEROIDAL ANTI-INFLAMMATORY DRUG AND INTERLEUKIN-1a PRODUC TION INHIBITOR |
| 02/22/2006 | EP1627642A2 Zinc free insulin crystals for use in pulmonary compositions |
| 02/22/2006 | EP1627637A1 Ophthalmic solution containing quinolone antimicrobial compound |
| 02/22/2006 | EP1627633A1 Oral pharmaceutical forms of administration with a delayed action with tramadol |
| 02/22/2006 | EP1627631A2 Morphine sulphate microgranules, method for preparing same and composition comprising same |
| 02/22/2006 | EP1627630A1 Dividable tablet |
| 02/22/2006 | EP1627629A1 Skin lotion |
| 02/22/2006 | EP1627571A1 Device for the administration of dietary supplements |
| 02/22/2006 | EP1627047A2 Methods for facilitating recovery of functions of endogenous or implanted or transplanted stem cells using high molecular weight hyaluronic acid |
| 02/22/2006 | EP1627039A2 Ingestible gastrointestinal device |
| 02/22/2006 | EP1626913A2 Stabilized pharmaceutical product |
| 02/22/2006 | EP1626746A2 Liquid aerosol formulations containing insulin and aerosol generating devices and methods for generating aerosolized insulin |
| 02/22/2006 | EP1626742A1 Sterilization of dispersions of nanoparticulate active agents with gamma radiation |
| 02/22/2006 | EP1626739A1 Compositionss for treating infection in cattle and swine |
| 02/22/2006 | EP1626709A1 Enantiomeric amphetamine compositions for the treatment of adhd |
| 02/22/2006 | EP1626707A2 Sustained release formulation of n-(2-propylpentanoyl) glycinamide and related compounds |
| 02/22/2006 | EP1626706A2 Dietary supplement and method for the treatment and prevention of digestive tract ulcers in equines and other animals |
| 02/22/2006 | EP1626705A1 Low sodium solution |
| 02/22/2006 | EP1626704A2 Dissolvable backing layer for use with a transmucosal delivery device |
| 02/22/2006 | EP1626697A2 Pharmaceutical compositions for oral administration comprising lithium carbonate |
| 02/22/2006 | EP1626695A2 Compositions and methods for reducing scar tissue formation |
| 02/22/2006 | EP1587869A4 Membrane active polymers |
| 02/22/2006 | EP1490029A4 Controlled release drug delivery system of pravastatin |
| 02/22/2006 | EP1384472B1 Method for producing an organic solvent-free lycopene concentrate, the resulting concentrate and composition comprising said concentrate |
| 02/22/2006 | EP1278818B1 Use of low ionic strength ophthalmic compositions |
| 02/22/2006 | EP1251857B1 Pharmaceutical parenteral composition containing a bisphosphonate |
| 02/22/2006 | EP1244805B1 Viral core protein-cationic lipid-nucleic acid-delivery complexes |
| 02/22/2006 | EP1208086B1 Benzamide formulation with histone deacetylase inhibitor activity |
| 02/22/2006 | EP1067914B1 Composition and method of preparing microparticles of water-insoluble substances |
| 02/22/2006 | EP1051193B1 Anhydrous topical skin preparation comprising ketoconazole |
| 02/22/2006 | EP0938301B2 Directly compressible lactitol and method |
| 02/22/2006 | EP0814837B2 Use of g class immunoglobulins for the topical treatment of atopic dermatitis |